PAPA (Papa Medical) Total Stockholders Equity: $3.77 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Papa Medical Total Stockholders Equity?

Papa Medical PAPA Total Stockholders Equity is $3.77 Mil as of Mar. 2025.

Papa Medical's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $3.77 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Papa Medical's Book Value per Share for the quarter that ended in Mar. 2025 was $0.18. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Papa Medical's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.69.

Papa Medical  (NAS:PAPA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Papa Medical's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(3.768-0)/21.250
=0.18

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Papa Medical's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.252 + 1.34) / 3.768
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical Total Stockholders Equity Related Terms

Papa Medical Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Papa Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical Total Stockholders Equity Chart

Papa Medical Annual Data
Trend Dec22 Dec23 Dec24
Total Stockholders Equity
0.71 2.31 2.98

Papa Medical Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 0.00 2.86 3.17 2.98 3.77
What does a Total Stockholders Equity of $3.77 Mil mean?
Papa Medical (PAPA) has a Total Stockholders Equity of $3.77 Mil as of Mar. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Papa Medical and its competitors.
Is Papa Medical's Total Stockholders Equity too high?
Papa Medical's current Total Stockholders Equity is $3.77 Mil.
How does Papa Medical's Total Stockholders Equity compare to ?
Papa Medical's Total Stockholders Equity of $3.77 Mil can be compared against companies in the Tobacco Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Tobacco Products company?
A good Total Stockholders Equity depends on the Tobacco Products industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Papa Medical and its competitors. Papa Medical's current Total Stockholders Equity is $3.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current Total Stockholders Equity of $3.77 Mil. The current Total Stockholders Equity is $3.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Papa Medical (PAPA), the current Total Stockholders Equity is $3.77 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.